Home / Inspections / 1308948

FDA Inspection 1308948 — SGS North America Inc.

SGS North America Inc. — FEI 1418028

The FDA completed an inspection of SGS North America Inc. on March 20, 2026 in Lincolnshire, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 20, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lincolnshire, IL (United States)

Facility

Other inspections at this facility

  • 1297328 (NAI Thu Sep 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1194448 (VAI Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1091237 (NAI Wed Apr 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1001725 (NAI Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904043 (NAI Fri Nov 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources